» Articles » PMID: 39988983

Longitudinal Patterns of Brain Aging and Neurodegeneration Among Older Adults with Dual Decline in Memory and Gait

Overview
Specialties Neurology
Psychiatry
Date 2025 Feb 24
PMID 39988983
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Dual cognitive and mobility decline is more strongly associated with dementia risk than cognitive decline only. It remains unknown whether this syndrome is associated with brain atrophy patterns, white matter (WM) damage, or pathology.

Methods: In the Baltimore Longitudinal Study of Aging participants with and without dual decline, we used linear mixed-effects models to compare up to 13-year longitudinal changes in MRI-derived atrophy patterns, WM hyperintensities (n = 339), microstructure (n = 307), plasma glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), amyloid beta 42/40 (Aβ) ratio (n = 349), and phosphorylated tau 181 (pTau181) (n = 258).

Results: Those experiencing dual decline showed accelerated atrophy in medial temporal (p = .004), parietotemporal (p = .029), and perisylvian regions (p = .028), whereas gait decline only showed accelerated parietotemporal atrophy (p = .035) and memory decline only showed perisylvian atrophy (p = .021). Dual decline was also associated with unique microstructural deterioration in several WM tracts (p < .05), a greater decrease in Aβ ratio (p = .015), and greater increases in GFAP (p = .009) and NfL (p < .001).

Discussion: Individuals experiencing dual decline are at an increased risk for regional brain atrophy, microstructural degradation, and biomarker-defined molecular changes underlying dementia.

Highlights: Those experiencing dual decline showed several accelerated brain atrophy patterns. Those experiencing dual decline showed unique microstructural deterioration. Dual decline showed a greater decline in plasma Aβ ratio. Dual decline showed greater increases in plasma GFAP and NfL. Dual decline may indicate brain and blood markers underlying dementia.

Citing Articles

Longitudinal patterns of brain aging and neurodegeneration among older adults with dual decline in memory and gait.

Tian Q, Greig E, Walker K, Duggan M, Yang Z, Moghekar A Alzheimers Dement. 2025; 21(2):e14612.

PMID: 39988983 PMC: 11848002. DOI: 10.1002/alz.14612.

References
1.
Sathyan S, Wang T, Ayers E, Verghese J . Genetic basis of motoric cognitive risk syndrome in the Health and Retirement Study. Neurology. 2019; 92(13):e1427-e1434. PMC: 6453764. DOI: 10.1212/WNL.0000000000007141. View

2.
Sultana M, Camicioli R, Dixon R, Whitehead S, Pieruccini-Faria F, Petrotchenko E . A Metabolomics Analysis of a Novel Phenotype of Older Adults at Higher Risk of Dementia. J Alzheimers Dis. 2023; 99(s2):S317-S325. DOI: 10.3233/JAD-230683. View

3.
Janelidze S, Stomrud E, Palmqvist S, Zetterberg H, van Westen D, Jeromin A . Plasma β-amyloid in Alzheimer's disease and vascular disease. Sci Rep. 2016; 6:26801. PMC: 4886210. DOI: 10.1038/srep26801. View

4.
Alexander D, Pierpaoli C, Basser P, Gee J . Spatial transformations of diffusion tensor magnetic resonance images. IEEE Trans Med Imaging. 2001; 20(11):1131-9. DOI: 10.1109/42.963816. View

5.
Beauchet O, Sekhon H, Barden J, Liu-Ambrose T, Chester V, Szturm T . Association of Motoric Cognitive Risk Syndrome with Cardiovascular Disease and Risk Factors: Results from an Original Study and Meta-Analysis. J Alzheimers Dis. 2018; 64(3):875-887. DOI: 10.3233/JAD-180203. View